Health Care & Life Sciences » Biotechnology | Kuros Biosciences Ltd.

Kuros Biosciences Ltd.

Kuros Biosciences Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
8.6 M
Public Float
-
Kuros Biosciences Ltd.
Stock Exchange SIX Swiss Exchange
EPS
CHF1.3
Market Cap
CHF26.74 M
Shares Outstanding
15.06 M
Public Float
10.09 M

Profile

Address
Wagistrasse 25
Schlieren Zurich 8952
Switzerland
Employees -
Website http://www.kurosbiosciences.com
Updated 07/08/2019
Kuros Biosciences Ltd. engages in the development of products for tissue repair and regeneration. Its products include sealants for tissue restore and orthobiologics for bone healing. The company was founded by Didier Cowling and Jason Schense in 2000 and is headquartered in Schlieren, Switzerland.

Financials

View All

Christian Martin Itin
Chairman
Gerhard Ries
Director